Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A quantum resistant chaos driven image encryption framework for secure visual data transmission in intelligent transportation systems.

Scientific reports·2026
Same author

Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance.

Future oncology (London, England)·2026
Same author

Impaired spatial coding and neuronal hyperactivity in the medial entorhinal cortex of aged APP knock-in mice.

Cell reports·2026
Same author

Sustainable EV adoption with clustering and predictive modelling for optimal charging infrastructure in the West Midlands and North East UK.

Scientific reports·2026
Same author

Drug Prescribing Patterns in Geriatric Patients With Type 2 Diabetes Mellitus at a Tertiary Care Teaching Hospital: A Cross-Sectional Study.

Cureus·2026
Same author

Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage Plasticity.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 18, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Inter-DRG resource dynamics in a prospective payment system: a stochastic kernel approach.

Anurag Sharma1

  • 1Centre for Health Economics, Monash University, Clayton 3800, Victoria, Australia. anurag.sharma@buseco.monash.edu.au

Health Care Management Science
|November 27, 2009
PubMed
Summary
This summary is machine-generated.

This study examines how resource distribution changes for elective surgery patients under a Prospective Payment System (PPS). Findings show redistribution can increase capacity and alter hospital case-mix, while improved care reduces high-cost outliers.

Related Experiment Videos

Last Updated: Jun 18, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Health Economics
  • Healthcare Management
  • Econometrics

Background:

  • Prospective Payment Systems (PPS) have been shown to reduce average Length of Stay (LOS) for surgical patients.
  • Limited research exists on how this LOS reduction is distributed across different Diagnosis Related Groups (DRGs) within a PPS framework.

Purpose of the Study:

  • To empirically investigate the dynamics of resource distribution across DRGs for elective surgery patients under an ongoing PPS.
  • To model the temporal evolution of the empirical distribution of LOS across DRGs.

Main Methods:

  • Utilized a non-parametric "stochastic kernel approach" rooted in Markov Chain theory.
  • Analyzed empirical distributions of LOS for inlier and high outlier patient episodes.

Main Results:

  • For inlier episodes, resource redistribution is projected to enhance capacity and expected admissions for DRGs with growing waiting times.
  • Hospitals interpret adjustments in relative cost weights as price signals, influencing their case-mix.
  • Improved quality of care emerged as a key factor in diminishing high outlier episodes.

Conclusions:

  • The study provides insights into DRG-specific resource allocation and LOS distribution under PPS.
  • Findings suggest that PPS mechanisms can drive both efficiency gains and shifts in hospital service provision.
  • Quality improvements play a significant role in managing high-cost patient care within PPS.